Axsome Therapeutics, Inc. Contracts & Agreements

57 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Axsome Therapeutics, Inc. Form of Restricted Stock Unit Agreement (Executives and Non-Employee Directors) pursuant to the Amended and Restated 2015 Omnibus Incentive Compensation...
Bonus & Incentive Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
2025
Axsome Therapeutics, Inc. Form of Restricted Stock Unit Agreement (Non-Executives) pursuant to the Amended and Restated 2015 Omnibus Incentive Compensation Plan
Bonus & Incentive Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
2025
Amendment to Sublease, dated January 17, 2025, between Advance Magazine Publishers Inc. d/b/a Condé Nast and Axsome Therapeutics, Inc
Lease Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
2025
Axsome Therapeutics, Inc. Form of Stock Option Agreement pursuant to the Amended and Restated 2015 Omnibus Incentive Compensation Plan
Bonus & Incentive Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
2025
Fifth Amendment to Hercules Loan and Security Agreement, dated September 30, 2024, by and among Axsome Therapeutics, Inc., the Lenders who from time to time may be party thereto,...
Loan Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
CA
2024
Axsome Therapeutics, Inc. Form of Stock Option Agreement pursuant to the Amended and Restated 2015 Omnibus Incentive Compensation Plan
Bonus & Incentive Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
DE
2024
Axsome Therapeutics, Inc. Form of Restricted Stock Unit Agreement (Non-Executives) pursuant to the Amended and Restated 2015 Omnibus Incentive Compensation Plan
Bonus & Incentive Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
DE
2024
Axsome Therapeutics, Inc. Form of Restricted Stock Unit Agreement (Executives and Non-Employee Directors) pursuant to the Amended and Restated 2015 Omnibus Incentive Compensation...
Bonus & Incentive Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
DE
2024
Axsome Therapeutics, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan
Bonus & Incentive Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
DE
2024
Fourth Amendment to Loan and Security Agreement, dated May 8, 2023, by and among Axsome Therapeutics, Inc., the Lenders who from time to time may be party thereto, and Hercules...
Loan Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
CA
2023
Underwriting Agreement, dated June 28, 2023, by and between Axsome Therapeutics, Inc. and SVB Securities LLC, as representative of the underwriters named therein
Underwriting Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2023
Axsome Therapeutics, Inc. 2023 Employee Stock Purchase Plan
Stock Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
DE
2023
Share Transfer Agreement, dated as of May 9, 2022, by and between Axsome Therapeutics, Inc., Hercules Capital, Inc., Hercules Private Global Venture Growth Fund I L.P., and...
Credit Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2022
Form of Warrant Agreement, dated as of May 9, 2022, between Axsome Therapeutics, Inc. and Hercules Capital, Inc
Warrant Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
CA
2022
Sales Agreement dated March 1, 2022, by and between Axsome Therapeutics, Inc. and SVB Securities LLC
Sales Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2022
Loan and Security Agreement, dated as of September 25, 2020, by and among Axsome Therapeutics, Inc., the Lenders who from time to time may be party thereto, and Hercules Capital,...
Loan Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
CA
2020
Warrant Agreement, dated as of September 25, 2020, by and between Axsome Therapeutics, Inc. and Hercules Capital, Inc
Warrant Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
CA
2020
Direct Agreement, by and among Axsome Therapeutics, Inc., Antecip Bioventures II LLC, and Hercules Capital Inc., as collateral agent for itself and the Lenders
Axsome Therapeutics, Inc.
Pharmaceuticals
CA
2020
WeWork Membership Agreement effective as of August 1, 2020, by and between the Company and 22 Cortlandt Street HQ LLC
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2020
Axsome Therapeutics, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan
Bonus & Incentive Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
DE
2020
Axsome Therapeutics, Inc. Form of Restricted Stock Unit Agreement pursuant to the 2015 Omnibus Incentive Compensation Plan
Bonus & Incentive Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
DE
2020
Description of Securities
Axsome Therapeutics, Inc.
Pharmaceuticals
2020
License Agreement, dated as of January 10, 2020, by and between the Company and Pfizer Inc
License Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2020
Share Transfer Agreement by and between Axsome Therapeutics, Inc. and Pfizer Inc
Stock Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2020
Underwriting Agreement, dated December 18, 2019, by and among Axsome Therapeutics, Inc., SVB Leerink LLC and Morgan Stanley & Co. LLC, as representatives of the underwriters named...
Underwriting Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2019
Sales Agreement dated December 5, 2019 by and between Axsome Therapeutics, Inc. and SVB Leerink LLC
Sales Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2019
Warrant to Purchase Stock made by the Company in favor of WestRiver Innovation Lending Fund VIII, L.P., dated July 25, 2019
Warrant Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
WA
2019
Warrant to Purchase Stock made by the Company in favor of Silicon Valley Bank, dated July 25, 2019
Warrant Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
CA
2019
Warrant to Purchase Stock made by the Company in favor of WestRiver Innovation Lending Fund VIII, L.P., dated March 5, 2019, as amended
Warrant Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
WA
2019
Warrant to Purchase Stock made by the Company in favor of Silicon Valley Bank, dated March 5, 2019, as amended
Warrant Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
CA
2019
First Amendment to Loan and Security Agreement dated as of July 25, 2019 by and among the Company, Silicon Valley Bank, in its capacity as administrative agent and collateral...
Loan Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
2019
Sales Agreement dated May 9, 2019 by and between Axsome Therapeutics, Inc. and SVB Leerink LLC
Sales Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2019
Form of Warrant, with respect to March 2019 Loan and Security Agreement
Loan Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
WA
2019
Form of Warrant, with respect to November 2018 First Amendment to Loan and Security Agreement
Loan Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
WA
2019
First Amendment to Loan and Security Agreement, dated as of November 26, 2018, by and between the Company and Silicon Valley Bank
Loan Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
2019
Loan and Security Agreement, dated as of March 5, 2019, by and among the Company, Silicon Valley Bank and WestRiver Innovation Lending Fund VIII, L.P
Loan Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
MA
2019
Form of Purchase Agreement, dated as of September 27, 2018, by and among Axsome Therapeutics, Inc. and the investors party thereto
Purchase Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2018
Nick Pizzie Offer Letter, dated April 16, 2018 (Incorporated by reference, Exhibit 10.1 to the Companys Quarterly Report on Form 10-Q, filed May 8, 2018)
Axsome Therapeutics, Inc.
Pharmaceuticals
2018
Nick Pizzie Offer Letter, dated April 16, 2018
Axsome Therapeutics, Inc.
Pharmaceuticals
2018
Engagement Letter, dated as of November 30, 2017 between Axsome Therapeutics, Inc. and H.C. Wainwright & Co., LLC
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2017
Form of Warrant
Warrant Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
2017
Form of Purchase Agreement, dated as of November 30, 2017 among Axsome Therapeutics, Inc. and the purchasers thereunder
Purchase Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2017
Sales Agreement dated October 20, 2017 by and between Axsome Therapeutics, Inc. and Leerink Partners LLC
Sales Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2017
John Golubieski Offer Letter, dated July 5, 2017
Axsome Therapeutics, Inc.
Pharmaceuticals
2017
Axsome Therapeutics, Inc. 3,743,316 Shares Common Stock ($0.0001 par value per share) Underwriting Agreement
Underwriting Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2017
WARRANT TO PURCHASE STOCK
Warrant Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
CA
2016
LOAN AND SECURITY AGREEMENT
Loan Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
MA
2016
WARRANT TO PURCHASE STOCK
Warrant Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
WA
2016
AXSOME THERAPEUTICS, INC. 2015 OMNIBUS INCENTIVE COMPENSATION PLAN
Bonus & Incentive Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
DE
2015
[] Shares AXSOME THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT [], 2015
Underwriting Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2015
AXSOME THERAPEUTICS, INC (A Delaware Corporation) WARRANT TO PURCHASE SHARES OF COMMON STOCK
Warrant Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2015
AXSOME THERAPEUTICS CONSULTING AGREEMENT
Consulting Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2015
Confidential Treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are...
Exchange Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2015
Confidential Treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are...
Exchange Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2015
Confidential Treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are...
Exchange Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2015
AXSOME THERAPEUTICS, INC. 2013 Equity Compensation Plan
Compensation Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
DE
2015
AXSOME THERAPEUTICS, INC (A Delaware Corporation) WARRANT TO PURCHASE [] SHARES OF COMMON STOCK
Warrant Agreements
Axsome Therapeutics, Inc.
Pharmaceuticals
NY
2015